https://www.ncf.net/clinical-trials-1/ide849 2026-04-11 https://www.ncf.net/clinical-trials-1/lanreotide-vs-placebo 2026-04-12 https://www.ncf.net/clinical-trials-1/tarlatamab 2025-12-14 https://www.ncf.net/clinical-trials-1/bravesst2 2025-12-07 https://www.ncf.net/clinical-trials-1/alpha-prrt-with-ryz401 2025-12-07 https://www.ncf.net/clinical-trials-1/uplift 2025-12-24 https://www.ncf.net/clinical-trials-1/study-of-225ac-abd147-to-establish-optimal-dose-in-patients-with-sclc-and-lcnec-of-the-lung-that-previously-received-platinum-based-chemotherapy 2025-12-03 https://www.ncf.net/clinical-trials-1/carefndr 2026-04-15 https://www.ncf.net/clinical-trials-1/zl-1310 2025-12-07 https://www.ncf.net/clinical-trials-1/stellar-311 2026-03-12 https://www.ncf.net/clinical-trials-1/dareon%E2%84%A2-7 2025-07-24 https://www.ncf.net/clinical-trials-1/svv-001 2026-01-13 https://www.ncf.net/clinical-trials-1/chm-2101-car-t 2025-12-07 https://www.ncf.net/clinical-trials-1/il13r%CE%B12-car-t 2026-02-06 https://www.ncf.net/clinical-trials-1/dareon9 2025-12-07 https://www.ncf.net/clinical-trials-1/lu-177 2025-12-07 https://www.ncf.net/clinical-trials-1/pb-212-vmt 2025-12-07 https://www.ncf.net/clinical-trials-1/lu-177-carboplatin 2025-12-07 https://www.ncf.net/clinical-trials-1/ac-225 2025-12-07 https://www.ncf.net/clinical-trials-1/dareon5 2025-12-07 https://www.ncf.net/clinical-trials-1/adct-701 2025-12-07 https://www.ncf.net/clinical-trials-1/nab-sirolimus 2025-12-07 https://www.ncf.net/clinical-trials-1/lampara 2025-12-07 https://www.ncf.net/clinical-trials-1/net-retreat 2026-01-13 https://www.ncf.net/clinical-trials-1/tissue-procurement 2025-12-07 https://www.ncf.net/clinical-trials-1/cdk46 2025-12-07 https://www.ncf.net/clinical-trials-1/netter-p 2025-12-07 https://www.ncf.net/clinical-trials-1/survivin-survaxm 2025-12-07 https://www.ncf.net/clinical-trials-1/systemic-vsv 2025-12-07 https://www.ncf.net/clinical-trials-1/olaparib 2025-12-07 https://www.ncf.net/clinical-trials-1/sorento 2025-12-07 https://www.ncf.net/clinical-trials-1/paltusotine 2025-12-07 https://www.ncf.net/clinical-trials-1/swog-s2012 2025-12-07 https://www.ncf.net/clinical-trials-1/belzutifan 2025-12-07 https://www.ncf.net/clinical-trials-1/swog-s2104 2025-12-07 https://www.ncf.net/clinical-trials-1/cabinet 2025-12-09 https://www.ncf.net/clinical-trials-1/alphamedix 2025-12-07 https://www.ncf.net/clinical-trials-1/action-1%3A-alpha-prrt-with-ac-225-in-gep-nets 2025-05-03 https://www.ncf.net/clinical-trials-1/lu-177-dotatate-m3814-peposertib 2025-12-07 https://www.ncf.net/clinical-trials-1/lu-177-dotatate-olaparib 2025-12-07 https://www.ncf.net/clinical-trials-1/lu-177-dotatate-triapine 2025-12-07 https://www.ncf.net/clinical-trials-1/lu-177-dotatate-cabozantanib 2025-12-07 https://www.ncf.net/clinical-trials-1/lu-177-dotatate 2025-12-07 https://www.ncf.net/clinical-trials-1/compose 2025-12-07 https://www.ncf.net/clinical-trials-1/comparenet 2025-12-07